Clincosm LogoSign in Get a demo

metastatic renal cell carcinoma

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • Nephrectomy
  • +4 more
  • Birmingham, Alabama
  • +414 more
Dec 30, 2022

Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +28 more
  • Conroe, Texas
  • +4 more
Dec 5, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • Birmingham, Alabama
  • +255 more
Aug 24, 2022

Malignant Tumors of Urinary Tract, Oligometastatic Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Houston

Recruiting
  • Malignant Neoplasms of Urinary Tract
  • +3 more
  • Stereotactic Body Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +17 more
  • Cryosurgery
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 29, 2021

Metastatic Renal Cell Carcinoma Trial in Canada, United States (AGS-16C3F, Axitinib)

Completed
Has Results
  • Metastatic Renal Cell Carcinoma
  • Tucson, Arizona
  • +25 more
Nov 9, 2021

Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (CB-839, Cabozantinib, Placebo)

Completed
  • Advanced Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • Birmingham, Alabama
  • +132 more
Aug 18, 2021

Metastatic Renal Cell Carcinoma Trial in Korea, Republic of, United States (CRLX101, Bevacizumab, Standard of Care (Investigator

Completed
  • Metastatic Renal Cell Carcinoma
  • La Jolla, California
  • +42 more
May 26, 2020

Treatment Patterns and Clinical Response in Malignancy

Completed
  • Metastatic Renal Cell Carcinoma
  • Metastatic Melanoma
    • Tucson, Arizona
    • +44 more
    Jun 11, 2019

    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,

    Terminated
    • Advanced Renal Cell Carcinoma
    • +2 more
    • Standard Treatment
    • AGS-003
    • Scottsdale, Arizona
    • +124 more
    Jun 13, 2018

    Metastatic Renal Cell Carcinoma Trial in United States (NST using MUD for metastatic renal cell carcinoma)

    Terminated
    • Metastatic Renal Cell Carcinoma
    • NST using MUD for metastatic renal cell carcinoma
    • Los Angeles, California
    • +4 more
    Jul 25, 2016

    Metastatic Renal Cell Carcinoma Trial in Houston (Tc 99m EC20)

    Completed
    • Metastatic Renal Cell Carcinoma
    • Tc 99m EC20
    • Houston, Texas
      Baylor College of Medicine
    Sep 17, 2012

    Metastatic Renal Cell Carcinoma Trial in Rochester, Houston (Technetium Tc 99m EC20)

    Completed
    • Metastatic Renal Cell Carcinoma
    • Technetium Tc 99m EC20
    • Rochester, Minnesota
    • +1 more
    Sep 17, 2012